Compare QNME & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QNME | PLSM |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Integrated Freight & Logistics | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4M | 12.2M |
| IPO Year | 2024 | 2025 |
| Metric | QNME | PLSM |
|---|---|---|
| Price | $0.48 | $1.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 7.4M | 37.6K |
| Earning Date | 11-18-2026 | 08-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.83 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,850,681.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 111.79 | N/A |
| 52 Week Low | $0.26 | $1.71 |
| 52 Week High | $1.40 | $12.97 |
| Indicator | QNME | PLSM |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 30.71 |
| Support Level | $0.50 | N/A |
| Resistance Level | $0.94 | $2.64 |
| Average True Range (ATR) | 0.10 | 0.18 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 6.26 | 11.69 |
Quanome Technologies Inc is a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea.
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.